CNBC August 10, 2023
Spencer Kimball

Key Points

– Medicare, in the coming weeks, will announce the 10 drugs that will be subject to price negotiations this year.

– It is the first time the program for seniors has directly negotiated prices with the pharmaceutical industry.

– It is still unclear which 10 drugs Medicare will select, but several pharmaceutical companies have already revealed in court filings that they expect four of their blockbuster medications to be targeted.

– The pharmaceutical industry has filed a torrent of lawsuits to block the negotiations, arguing that the program is an unconstitutional seizure of their property.

Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Medicare’s New Mandatory Bundled-Payment Program — Are We Ready for TEAM?
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Biden administration pushes anti-obesity drug pressure to Trump
Health Leaders Applaud Biden’s Proposal to Expand Medicare/Medicaid Coverage for Anti-Obesity Medications

Share This Article